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Abstract Interferon gamma (IFN-Q) induces apoptosis in many
tumor cell lines and sensitizes tumor cells to apoptosis by tumor
necrosis factor family members. IFN-Q induces the expression of
many early response genes such as interferon regulatory factor-1
(IRF-1) by activation of signal transducer and activator of
transcription (STAT) factor proteins. We found that ME180
cells became resistant to IFN-Q-induced cell death after 4^5
passages in culture. These resistant cells were characterized by a
loss of STAT1 expression and a loss of inducible IRF-1
expression. We describe for the first time the emergence of a
STAT1-deficient ME180 cell line.
z 1999 Federation of European Biochemical Societies.
Key words: Apoptosis; Interferon regulatory factor-1;
Signal transducer and activator of transcription-1; ME180;
Resistance
1. Introduction
Interferon gamma (IFN-Q) is a cytokine that plays an im-
portant role in immune surveillance and host defense against
infection. Recent studies show that IFN-Q induces apoptosis in
many tumor cell lines [1^3]. IFN-Q also sensitizes tumor cell
lines to apoptosis by members of the tumor necrosis factor
(TNF) family such as TNF, Fas and TNF-related apoptosis-
inducing ligand (TRAIL), also known as Apo2L [3^6]. Several
candidate genes have been identi¢ed which may mediate IFN-
Q-induced apoptosis such as interleukin-1L-converting enzyme
(ICE) (caspase-1) and DAP-kinase [2,6,7]. Overexpression of
DAP-kinase in HeLa cells, for example, causes apoptosis and
reduced DAP-kinase levels in some solid tumors inhibit apop-
tosis and enhance tumor metastasis [7,8]. Overexpression of
caspase-1 has also been shown to induce apoptosis [2,6]. It is
not clear, however, if caspase-1 alone directly activates an
apoptotic signaling pathway.
IFN-Q induces the expression of many early response genes
by tyrosine phosphorylation of Jak kinases and signal trans-
ducer and activator of transcription (STAT) transcription fac-
tor proteins [9,10]. The Jak/STAT pathway is responsible for
initial transmission of the IFN-Q signal to the nucleus but
proper regulation of the many genes induced by IFN-Q in-
volves other transcription factors such as interferon regula-
tory factor-1 (IRF-1) [11]. Induction of IRF-1 is dependent
on the STAT1 protein [12,13]. Several studies have shown that
IRF-1 is not only a transcriptional activator but it is also a
critical mediator of radiation- and chemotherapy-induced
apoptosis and cell cycle arrest [1,14,15]. IRF-1, for example,
cooperates with p53 to induce p21 and mediate cell cycle
arrest in response to DNA damage [16].
Recent studies have shown that STAT1 plays a key role in
induction of apoptosis by TNF and IFN-Q. For example, Ku-
mar et al. [17] showed that cells that lack STAT1 are resistant
to apoptosis because of low constitutive levels of caspases.
Chin et al. [2] showed that activation of the STAT signaling
pathways in tumor cells causes expression of caspase-1 and
apoptosis. Expression of ICE was shown to be essential for
IFN-Q-induced apoptosis. These studies suggest a role for
STAT1 in coordinating caspase-dependent apoptotic path-
ways mediated by IFN-Q and TNF.
There are some studies, however, which show that IFN-Q
induces cell death by a non-caspase-mediated mechanism
[18,19]. For example, in the ME180 cervical carcinoma cell
line and A549 non-small cell lung cancer cell line, studies
show that IFN-Q induces cell death by depletion of tryptophan
and intracellular nicotinamide adenine dinucleotide [18,19].
Aune and Pogue [18] showed that IFN-Q does not induce
DNA strand breaks in ME180 and A549 cells which suggests
a non-caspase-mediated cell death.
We found, however, that cell death induced by IFN-Q in
ME180 cells is mediated by caspases because cell death was
almost completely blocked by z-VAD.fmk, a tetrapeptide cas-
pase inhibitor. We also observed that ME180 cells become
resistant to the cytotoxic e¡ects of IFN-Q after 4^5 passages
in culture. In comparing ME180 cells that became resistant to
IFN-Q (ME180R) to ME180 sensitive cells (ME180S), we
found that STAT1 protein expression was lost in ME180R
cells and IRF-1 was not induced in response to IFN-Q. Over-
expression of IRF-1 induced cell death in ME180R cells so
that loss of sensitivity to IFN-Q likely results from a loss of
STAT1 and inducible IRF-1 expression in ME180R cells. This
is the ¢rst example of the emergence in tissue culture of a
STAT1-de¢cient cell line.
2. Materials and methods
2.1. Cell culture
The ME180 cell line was purchased from ATCC (Rockville, MD).
ME180 cells were cultured in either McCoy’s medium with 10% fetal
calf serum or RPMI 1640 with 5% fetal calf serum and 5% newborn
calf serum supplemented with L-glutamine, penicillin and streptomy-
cin.
2.2. Cell viability assay
Cell viability was measured by an MTT assay. Brie£y, untreated
cells or cells treated with IFN-Q in a 96-well plate were harvested at
the indicated times followed by the addition of 3-(4,5-dimethylthiazol-
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2-yl)-2,5-diphenyltetrazolium bromide (MTT) and then cells were
solubilized with 0.1 N acidi¢ed CH3Cl-HCl. The 96-well plate was
read at a wavelength of 590 nm on an iEMS Labsystems plate reader.
The e¡ect of IRF-1 on cell viability in ME180R cells was examined by
transient transfection of ME180R cells by lipofectamine in a 12-well
culture dish (5U104 cells/well) with 100 ng of the reporter plasmid
pcDNA3-L-galactosidase plus 0^400 ng of pCEP4-IRF-1. The total
amount of transfected DNA was kept constant at 0.5 Wg with the
addition of the parental pCEP4 vector. Non-apoptotic or apoptotic
cells were detected by staining with 5-bromo-4-chloro-3-indolyl L-D-
galactopyranoside. Percent viable cells represents the number of blue
cells for each condition/total number of blue cells in control (pCEP4).
Data are the mean values from three experiments (mean þ S.D.).
2.3. Cytokines, antibodies, and inhibitors
IFN-Q with a speci¢c activity of 1U107 IU/ ml was purchased from
Biosource Int. (Camarillo, CA). z-VAD.fmk was purchased from En-
zyme Systems Products (Dublin, CA). Anti-IRF-1 polyclonal rabbit
antibody was purchased from Santa Cruz Biotechnology (Santa Cruz,
CA). ICE polyclonal antibodies was purchased from UBI Systems
(Lake Placid, NY). Caspase-3 and STAT1 monoclonal antibodies
were purchased from Transduction laboratories (Lexington, KY). A
polyclonal rabbit ERK2 antibody was from Calbiochem (La Jolla,
CA).
2.4. Northern blot analysis
RNA was harvested from A549 cells with a RNA STAT-60, a
solution containing guanidine isothiocyanate and phenol (Tel-Test
‘B’, Friendswood, TX) and Northern blot analysis was done as pre-
viously described [3]. The STAT1 cDNA was obtained from James
Darnell (Rockefeller University, New York, NY). The IRF-1 human
cDNA was generated as previously described [3].
2.5. Antibodies and immunoblotting
Western blot analysis was done essentially as described [20]. Brie£y,
ME180 cells were treated with IFN-Q for the indicated times and then
were lysed in a boiling solution containing 1% SDS, 1 mM sodium
vanadate and 10 mM Tris-HCl pH 7.4. Samples were centrifuged for
5 min to remove insoluble material followed by measurement of pro-
tein concentration by the Bradford method (Bio-Rad Laboratories,
Hercules, CA). Samples containing equal protein concentrations
were denatured by boiling and analyzed by SDS-PAGE, and then
transferred to nitrocellulose. The blot was then placed in blocking
bu¡er containing 1% milk, 1% BSA, 10 mM Tris-HCl pH 7.5, 100
mM NaCl, and 0.1% Tween 20 for 1 h at room temperature or over-
night at 4‡C. The blot was then incubated in blocking bu¡er with
individual antibodies in a solution which contained 10 mM Tris-
HCl pH 7.5, 100 mM NaCl, and 0.1% Tween 20 followed by incuba-
tion in blocking bu¡er containing a horseradish peroxidase-conju-
gated anti-rabbit IgG or anti-mouse IgG (Caltag Laboratories, San
Francisco, CA) at a dilution of 1:1500 and detected by ECL (Amer-
sham, Arlington Heights, IL) followed by autoradiography.
3. Results and discussion
We have examined multiple tumor cell lines for sensitivity
to IFN-Q-induced cell death. Several studies have suggested
that IFN-Q-induced cell death is mediated by caspase-1
[1,6,21]. There is one recent study that showed IFN-Q induces
bak mRNA in HT-29 colon cancer cells along with several
caspases [16]. We observed that IFN-Q induces cell death in
approximately 50% of cells in the ME180 cervical carcinoma
cell line (Fig. 1A). IFN-Q-induced cell death was blocked by
z-VAD.fmk, a tetrapeptide caspase inhibitor (Fig. 1A). Cell
death induced by IFN-Q was con¢rmed as apoptotic in
ME180S cells by annexin staining (data not shown). Interest-
ingly, the ME180 cell line became almost completely resistant
to IFN-Q-induced cell death after 4^5 passages in culture (Fig.
1B). Simply culturing the ME180 cells in serum-containing
medium induced resistance to IFN-Q-induced cell death. The
use of di¡erent medium preparations, McCoy versus RPMI,
or reduced fetal calf serum concentrations did not a¡ect the
emergence of IFN-Q-resistant ME180 cells. The cells had not
been exposed to IFN-Q and several di¡erent aliquots from
ATCC showed the same emergence of resistance.
To characterize the defect in ME180R cells which abrogates
IFN-Q-induced cell death we ¢rst examined expression of IRF-
1, a critical regulator of IFN-Q-induced apoptosis. Basal levels
of IRF-1 mRNA were similar in both ME180S and ME180R
cells but IRF-1 mRNA was induced in response to IFN-Q only
in ME180S cells (Fig. 2A). We then examined IRF-1 protein
in both sensitive and resistant cells and inducible IRF-1 was
detected only in ME180S cells (Fig. 2B). These results show
that expression of inducible IRF-1 mRNA and protein is lost
in ME180R cells.
Expression of IRF-1 has been shown to be dependent on
STAT1, so we examined STAT1 expression in both sensitive
and resistant ME180 cells. Two forms of STAT1 mRNA were
observed by Northern blot both of which were reduced at
baseline and in response to IFN-Q in ME180R cells (Fig.
3A). STAT1 protein was induced by IFN-Q in ME180S cells
but there was almost no basal or inducible STAT1 expression
in ME180R cells (Fig. 3B). We did observe barely detectable
levels of STAT1 protein in ME180R cells with overexposure
of the Western blot (data not shown). These results suggest
that loss of inducible IRF-1 is secondary to a defect in STAT1
expression in ME180R cells.
A central role for IRF-1 in mediating cell death responses
to chemotherapy and radiation has been described, so we
Fig. 1. Loss of IFN-Q-induced apoptosis in ME180 cells. A: MTT
assay shows % viable ME180 cells after treatment with IFN-Q (250
U/ml) for 48 h in the presence or absence of z-VAD.fmk (40 WM).
Cells were pretreated with z-VAD.fmk for 2 h prior to the addition
of IFN-Q. B: MTT assay of ME180S and ME180R cells exposed to
IFN-Q for 48 h. Data represent means of three experiments þ S.D.
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hypothesized that loss of IRF-1 in ME180R cells was respon-
sible for the defect in IFN-Q-induced apoptosis. To examine
this possibility we overexpressed IRF-1 in ME180R cells and
we observed an over 50% reduction in cell viability in
ME180R cells in comparison to a transfected vector control
(Fig. 4). These data show that we can reconstitute a cell death
response in ME180R cells with overexpression of IRF-1. In-
terestingly, ME180R but not ME180S cells were also resistant
to TNF-K-induced apoptosis but they remained sensitive to
cell death induced by TRAIL, also known as Apo2L (K.Y.
Lee and G.D. Rosen, unpublished observations).
Recent studies suggest a key role for STAT1 in coordinat-
ing apoptotic responses to IFN-Q and TNF [2,17]. Addition-
ally, loss of STAT1 expression appears to result in decreased
expression of caspase-1 and caspase-3 [17]. Also, activation of
the STAT signaling pathway and ICE gene expression appears
to be necessary for IFN-Q-induced apoptosis [2]. We observed
that STAT1 expression was almost completely absent in
ME180R cells (Fig. 3). We hypothesized, therefore, that ex-
pression of caspase-1 and caspase-3 would be decreased in
ME180R cells in comparison to ME180S cells. However, we
observed signi¢cant levels of caspase-1 and caspase-3 in both
ME180S and ME180R cell lines and the levels were similar
(Fig. 5). There was, however, a modest induction of caspase-1
and caspase-3 in response to IFN-Q in ME180S cells which
was not observed in ME180R cells (Fig. 5). These data show
that STAT1 is not required for expression of constitutive cas-
pase-1 and caspase-3 in ME180 cells but may be necessary for
inducible caspase expression.
We are presently investigating the mechanism responsible
for reduced STAT1 mRNA and almost complete loss of
STAT1 protein in ME180R cells. We hypothesized that di¡er-
ences in medium contents or serum concentrations may a¡ect
the emergence of a resistant phenotype but altering culturing
conditions did not prevent the emergence of resistance. It is
possible that levels of regulatory proteins in the STAT1 gene
which control its expression are reduced in culturing of
ME180 cells. A loss of STAT1 expression has not, however,
been reported in other cell lines so that ME180 cells may be
unique in their response to passage in culture. There is no
Fig. 2. Inducible expression of IRF-1 is lost in ME180R cells. A:
ME180S and ME180R cells were treated for 6 h with IFN-Q and
then RNA was extracted for Northern blot analysis of IRF-1. Each
lane contains 10 Wg of total RNA and the blot was probed with a
32P-labeled 400 bp IRF-1 cDNA. The lower band corresponds to a
size of 2.0 kb which is the predicted size of IRF-1. The upper band
migrates at approximately 3.0 kb and likely represents an alterna-
tively spliced IRF-1 cDNA. B: Western blot analysis of ME180S
and ME180R cells treated for 8 h with IFN-Q. Cellular protein was
harvested followed by loading of equal amounts of protein on an
SDS-PAGE gel which was probed with an anti-IRF-1 polyclonal
antibody after transfer to nitrocellulose.
Fig. 3. STAT1 expression is markedly reduced in ME180R cells. A:
Northern blot analysis of STAT1 mRNA in ME180S and ME180R
cells treated with IFN-Q for 6 h. The blot was stripped and re-
probed with glyceraldehyde 3-phosphate dehyrogenase (GAPDH)
cDNA as a loading control. B: ME180S and ME180R cells were
treated with IFN-Q also for 8 h and then harvested for Western blot
analysis with a monoclonal STAT1 antibody. The blot was stripped
and reprobed with an ERK2 antibody as a loading control.
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global defect in the response of ME180R cells to apoptotic
stimuli because overexpression of IRF-1 reconstitutes the cell
death response.
We have shown that IFN-Q induces a caspase-mediated cell
death in ME180 cells. ME180 cells become resistant to IFN-Q-
induced cell death after 4^5 passages in culture. The ME180R
cells are characterized by a loss of STAT1 expression and the
loss of STAT1 likely results in loss of inducible IRF-1 expres-
sion. Loss of STAT1 does not, however, a¡ect expression of
constitutive levels of caspase-1 and caspase-3. It will be inter-
esting to examine if other tumor cell lines or primary tumors
show defects in STAT1 expression which may mediate resist-
ance to cytotoxic agents.
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Fig. 5. Expression of basal caspase-1 and caspase-3 is similar in
ME180S and ME180R cells. ME180S and ME180R cells were
treated with IFN-Q for 6 h and then harvested for Western blot
analysis with a monoclonal caspase-3 antibody. The blot was then
stripped and reprobed with a polyclonal caspase-1 antibody.
Fig. 4. Overexpression of IRF-1 induces cells death in ME180R
cells. ME180R cells were transfected with increasing amounts of
pCEP4-IRF-1 or pCEP4 (vector control) alone with a reporter gene
(L-galactosidase). Transfected cells were stained with 5-bromo-4-
chloro-3-indolyl L-D-galactopyranoside and examined by phase con-
trast microscopy 36 h after transfection. Data represent the percent
viable cells which is calculated as the number of LacZ-positive cells
for each condition/total number of LacZ cells in control (pCEP4).
The data are the means of three experiments þ S.D.
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